Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pleural Fluid pH Measured with Blood Gas Analyzer

By LabMedica International staff writers
Posted on 24 Jun 2013
The measurement of pleural fluid pH can be a clinically useful tool in the management of patients with parapneumonic effusions, which may be a symptom of underlying illness.

Pleural fluid pH testing is now offered on the RAPIDPoint 500 Blood gas system, providing US laboratories and point-of-care coordinators with an important new diagnostic tool for critical care situations. More...
RAPIDPoint 500 Blood Gas Analyzers deliver accurate, laboratory-quality test results from a single sample and for multiple sample types (pleural fluids, whole blood, or dialysate fluids).

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) has obtained US Food and Drug Association (FDA; Atlanta GA, USA) clearance to offer pleural fluid pH testing on its RAPIDPoint 500 Blood Gas System. The addition of pleural fluid pH testing on the company’s RAPIDPoint 500 System complements the analyzer’s comprehensive critical care menu, which includes tests for blood gases, electrolytes, glucose, lactate, and full CO-oximetry, including neonatal total bilirubin and total hemoglobin.

When a patient’s pleural fluid pH is less than 7.30 (normal pleural fluid pH is estimated at 7.64), it may imply the presence of an inflammatory or infiltrative process. These measurements can be taken using pH meters or indicator sticks, but multiple studies have shown that these methods are less accurate than readings conducted with blood gas analyzers. The American College of Chest Physicians (ACCP) recommends blood gas analyzers as the preferred pleural fluid chemistry test for categorizing and managing parapneumonic effusions.

The RAPIDPoint 500 system leverages Siemens technology to deliver laboratory-quality results in approximately 60 seconds from a single, whole blood sample. In addition, the analyzer’s measurement cartridges last up to 28 days and contain a full complement of tests, reducing downtime.

Related Links:

Siemens Healthcare Diagnostics
US Food and Drug Association



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.